Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) shares traded 11.47% higher at $0.72 on Wall Street last session.
IRWD stock price is now -53.18% away from the 50-day moving average and -81.13% away from the 200-day moving average. The market capitalization of the company currently stands at $116.86M.
, while ‘Citizens JMP’ rates the stock as ‘Mkt Perform’
In other news, MCCOURT Thomas A, Chief Executive Officer sold 139,064 shares of the company’s stock on Feb 10 ’25. The stock was sold for $244,753 at an average price of $1.76. Upon completion of the transaction, the Chief Executive Officer now directly owns 1,160,634 shares in the company, valued at $0.84 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 10 ’25, Principal Accounting Officer Silver Ronald sold 12,048 shares of the business’s stock. A total of $21,204 was realized by selling the stock at an average price of $1.76. This leaves the insider owning 279,655 shares of the company worth $0.2 million. A total of 3.18% of the company’s stock is owned by insiders.
During the past 12 months, Ironwood Pharmaceuticals Inc has had a low of $0.59 and a high of $8.45. According to the stock market information, the enterprise value for the company is $627780800, which is based on a 66.87 price-to-earnings ratio, a 0.47 price-to-earnings-growth ratio, and a beta of 0.51. The fifty day moving average price for IRWD is $1.5428 and a two-hundred day moving average price translates $3.82725 for the stock.
The latest earnings results from Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was released for 2024-12-31. The net profit margin was 0.52% and return on equity was -559.14% for IRWD. The company reported revenue of $90.55 million for the quarter, compared to $117.55 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -22.98 percent.
